109 related articles for article (PubMed ID: 20727346)
21. Thermodynamic investigation into the mechanisms of proton-coupled electron transfer events in heme protein maquettes.
Reddi AR; Reedy CJ; Mui S; Gibney BR
Biochemistry; 2007 Jan; 46(1):291-305. PubMed ID: 17198400
[TBL] [Abstract][Full Text] [Related]
22. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
Kenakin TP
J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
[TBL] [Abstract][Full Text] [Related]
23. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
Zhorov BS; Ananthanarayanan VS
Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
[TBL] [Abstract][Full Text] [Related]
24. Deducing the energetic cost of protein folding in zinc finger proteins using designed metallopeptides.
Reddi AR; Guzman TR; Breece RM; Tierney DL; Gibney BR
J Am Chem Soc; 2007 Oct; 129(42):12815-27. PubMed ID: 17902663
[TBL] [Abstract][Full Text] [Related]
25. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
26. Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.
Bhattacharya S; Vaidehi N
J Am Chem Soc; 2010 Apr; 132(14):5205-14. PubMed ID: 20235532
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional models for agonist and antagonist complexes with beta 2 adrenergic receptor.
Kontoyianni M; DeWeese C; Penzotti JE; Lybrand TP
J Med Chem; 1996 Oct; 39(22):4406-20. PubMed ID: 8893835
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
MacEwan DJ; Kim GD; Milligan G
Mol Pharmacol; 1995 Aug; 48(2):316-25. PubMed ID: 7651365
[TBL] [Abstract][Full Text] [Related]
29. Observation of "ionic lock" formation in molecular dynamics simulations of wild-type beta 1 and beta 2 adrenergic receptors.
Vanni S; Neri M; Tavernelli I; Rothlisberger U
Biochemistry; 2009 Jun; 48(22):4789-97. PubMed ID: 19378975
[TBL] [Abstract][Full Text] [Related]
30. Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits.
Onaran HO; Costa T; Rodbard D
Mol Pharmacol; 1993 Feb; 43(2):245-56. PubMed ID: 8381511
[TBL] [Abstract][Full Text] [Related]
31. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
[TBL] [Abstract][Full Text] [Related]
32. Ligand-binding modes in cationic biogenic amine receptors.
Ishiguro M
Chembiochem; 2004 Sep; 5(9):1210-9. PubMed ID: 15368572
[TBL] [Abstract][Full Text] [Related]
33. Mechanism-based pharmacodynamic modeling of S(-)-atenolol: estimation of in vivo affinity for the beta1-adrenoceptor with an agonist-antagonist interaction model.
van Steeg TJ; Freijer J; Danhof M; de Lange EC
J Pharmacol Exp Ther; 2008 Mar; 324(3):1234-42. PubMed ID: 18162599
[TBL] [Abstract][Full Text] [Related]
34. A functional beta-2 adrenoceptor-mediated chronotropic response in isolated guinea pig heart tissue: selectivity of the potent beta-2 adrenoceptor agonist TA 2005.
Voss HP; Shukrula S; Wu TS; Donnell D; Bast A
J Pharmacol Exp Ther; 1994 Oct; 271(1):386-9. PubMed ID: 7965739
[TBL] [Abstract][Full Text] [Related]
35. Thermodynamics of melittin binding to lipid bilayers. Aggregation and pore formation.
Klocek G; Schulthess T; Shai Y; Seelig J
Biochemistry; 2009 Mar; 48(12):2586-96. PubMed ID: 19173655
[TBL] [Abstract][Full Text] [Related]
36. The role of conformational ensembles of seven transmembrane receptors in functional selectivity.
Vaidehi N; Kenakin T
Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468
[TBL] [Abstract][Full Text] [Related]
37. GPCR activation: a mutagenic spotlight on crystal structures.
Hulme EC
Trends Pharmacol Sci; 2013 Jan; 34(1):67-84. PubMed ID: 23245528
[TBL] [Abstract][Full Text] [Related]
38. The Energetics of Chromophore Binding in the Visual Photoreceptor Rhodopsin.
Tian H; Sakmar TP; Huber T
Biophys J; 2017 Jul; 113(1):60-72. PubMed ID: 28700926
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists.
Furse KE; Lybrand TP
J Med Chem; 2003 Oct; 46(21):4450-62. PubMed ID: 14521408
[TBL] [Abstract][Full Text] [Related]
40. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor.
Ghanouni P; Gryczynski Z; Steenhuis JJ; Lee TW; Farrens DL; Lakowicz JR; Kobilka BK
J Biol Chem; 2001 Jul; 276(27):24433-6. PubMed ID: 11320077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
